
About Shifa Remedies
Shifa Remedies is a Healthcare company based in Delhi (India) founded in 2021. It manufactures haemodialysis powder concentrates and supplies to dialysis service providers. It operates on a B2B model. Its Indian entity Shifa Remedies Private Limited reported revenue of ₹37.06 Cr. Shifa Remedies offers products and services including DRY CITRASATE SR–BICARB-CL, DRY BICARBONATE CONCENTRATE, FISTULA NEEDLE, BLOOD TUBING, and DIALYZER. Its focus areas include Medical Devices, Dialysis and Haemodialysis Concentrates.
Company details
Shifa Remedies, established in 2005, focuses on producing and marketing haemodialysis powder concentrates as the exclusive licensee for DRY CITRASATE in India and neighboring countries. They supply products to major dialysis service providers through a pan-India distribution network. Based in New Delhi, the company emphasizes quality and innovation in medical devices for patient care, serving healthcare facilities across the region.
- Headquarters Delhi, India
- SectorsHealthcare
- Email••••••••
- Website shifaremedies.in
- Legal Name Shifa Remedies Private Limited
- Date of Incorporation 20 Apr, 2005
- Jurisdiction New Delhi, Delhi, India
- Annual Revenue₹37.06 Cr
FY 2025 · +6% YoY
- Net Profit₹73.3 Lakh
FY 2025 · 2% margin
- EBITDA₹1.75 Cr
FY 2025 · 5% margin
Associated legal entities of Shifa Remedies
Shifa Remedies operates through Shifa Remedies Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Shifa Remedies Private Limited CIN U24232DL2005PTC135134 | Active | 20 Apr 2005 | New Delhi, Delhi | ₹37.1 Cr | 4 | View details |
Products & Services of Shifa Remedies
Shifa Remedies offers a comprehensive portfolio of products and services, including DRY CITRASATE SR–BICARB-CL, DRY BICARBONATE CONCENTRATE, FISTULA NEEDLE, BLOOD TUBING, and DIALYZER.
Haemodialysis concentrate for improved dialysis treatment efficacy.
Bicarbonate-based solution for haemodialysis processes.
Needle for vascular access in dialysis procedures.
Tubing system for blood circulation during dialysis.
Filter device used in haemodialysis treatments.
Machine for mixing dialysis concentrates accurately.
Board of directors of Shifa Remedies Private Limited (Shifa Remedies)
Shifa Remedies Private Limited is the primary company behind Shifa Remedies. The board of Shifa Remedies Private Limited currently have 4 directors; the longest-serving is Arif Sayeed Khan, appointed in 2005. 1 earlier director has ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Arif Sayeed Khan DIN 01390254 | Director | 20 Apr 2005 | 21 yrs 6 mo | Shifa Remedies Private Limited |
| Mohammad Tariq DIN 01390336 | Director | 20 Apr 2005 | 21 yrs 6 mo | Shifa Remedies Private Limited |
| Asif S Khan DIN 01546934 | Director | 11 Feb 2008 | 18 yrs 9 mo | Shifa Remedies Private Limited |
| Akbar Khan DIN 10479752 | Additional Director | 22 Dec 2025 | 10 mo | Shifa Remedies Private Limited |
Financials of Shifa Remedies
Figures of Shifa Remedies Private Limited, the primary company behind Shifa Remedies, for FY 2025. Revenue was ₹37.06 Cr (+6% year on year). Net profit was ₹73.3 Lakh (2% margin). EBITDA was ₹1.75 Cr (5% margin). Revenue has grown at a compounded annual rate of +27% over three years and +13% over five years.
- ₹37.06 CrRevenue · FY 2025 · +6% YoY
- ₹73.3 LakhNet profit · 2% margin
- ₹1.75 CrEBITDA · 5% margin
- ₹1 LakhPaid-up capital
- +27%Revenue CAGR, 3 years
- +13%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Shifa Remedies Private Limited are on its company page.
Detailed financial statements for Shifa Remedies
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Shifa Remedies
Shifa Remedies was founded in 2021.
Shifa Remedies is headquartered in Delhi, India. It is registered at Delhi, Delhi, India.
The primary company behind Shifa Remedies, Shifa Remedies Private Limited, reported revenue of ₹37.06 Cr for FY 2025, up 6% year on year.
Shifa Remedies, established in 2005, focuses on producing and marketing haemodialysis powder concentrates as the exclusive licensee for DRY CITRASATE in India and neighboring countries. They supply products to major dialysis service providers through a pan-India distribution network. Based in New Delhi, the company emphasizes quality and innovation in medical devices for patient care, serving healthcare facilities across the region.
Shifa Remedies offers DRY CITRASATE SR–BICARB-CL, DRY BICARBONATE CONCENTRATE, FISTULA NEEDLE, BLOOD TUBING, and 2 more products and services.
Shifa Remedies operates through Shifa Remedies Private Limited.
The legal entities of Shifa Remedies currently have 4 directors, including Arif Sayeed Khan, Mohammad Tariq, Asif S Khan and others.